MRIMath

Company profile

About MRIMath

MRIMath is a Birmingham, Alabama-based medical imaging AI company that delivers FDA 510(k)-cleared solutions for brain tumor analysis and treatment planning. The company's flagship platform combines AI-powered segmentation with secure cloud-based collaboration tools, enabling healthcare professionals to analyze glioblastoma (GBM) and other brain tumors with unprecedented speed and accuracy. MRIMath's core technology uses advanced AI models to generate neuro-radiologist-level tumor segmentations in seconds—up to 30× faster than manual contouring methods—while maintaining accuracy rates of 92-95% for GBM on FLAIR and T1c MRI sequences. The platform includes smart manual segmentation tools with inter-user variability below 5%, AI-driven segmentation for GBM, metastatic brain tumors, and organs-at-risk, plus volumetric measurement and tracking capabilities. Built with government-grade cybersecurity and HIPAA compliance, MRIMath's cyber device enables real-time collaboration across institutions through its TeamSpace feature, allowing clinicians to work securely from anywhere. The company serves radiation oncologists, neuro-oncologists, radiologists, and researchers at major academic medical centers and health systems. MRIMath's mission is to raise the bar of physician and patient expectations by using reliable AI and machine learning to help doctors make better decisions that improve patient lives, with a vision to become the world's most physician-centric and patient-appreciated medical imaging company.

Company description · MRIMath official website